CRISTIAN COARFA to Benzimidazoles
This is a "connection" page, showing publications CRISTIAN COARFA has written about Benzimidazoles.
Connection Strength
0.182
-
Pharmacological inhibition of CaMKK2 with the selective antagonist STO-609 regresses NAFLD. Sci Rep. 2017 09 18; 7(1):11793.
Score: 0.126
-
Defective DNA Damage Response Is a Targetable Therapeutic Vulnerability in ESR1-Mutant Breast Cancer. Cancer Res. 2026 Apr 02; 86(7):1707-1723.
Score: 0.057